Updates are available Correction dated 2025-01-09
Click to view Correction: https://doi.org/10.1038/s41533-024-00411-9
-
Authors
Skolnik, Neil
Yawn, Barbara P.
Correia de Sousa, Jaime
Vázquez, María Mar Martínez
Barnard, Amanda
Wright, Wendy L.
Ulrich, Austin
Winders, Tonya
Brunton, Stephen
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 4 November 2024
First Online: 17 November 2024
Change Date: 9 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41533-024-00411-9
Competing interests
: N.S. reports the following competing interests: Advisory Boards and Consultant - AstraZeneca, Teva, Lilly, Boehringer Ingelheim, Sanofi, Sanofi Pasteur, GSK, Bayer, Genentech, Abbott, Idorsia, Novartis, Novo Nordisk, Astellas; Speaker - AstraZeneca, Boehringer Ingelheim, Lilly, GSK, Teva, Bayer, Heartland, Astellas; Research Support - AstraZeneca, GSK, Novo Nordisk, Novartis. B.P.Y. reports the following competing interests: consultant and member of advisory boards related to asthma for AstraZeneca, GlaxoSmithKline, TEVA, Novartis, and Moderna. J.C.S. reports the following competing interests: Chair of the Asthma Right Care Strategy Team: International Primary Care Respiratory Group; Receipt of grants/research support: AstraZeneca and GSK; Receipt of honoraria or consultation fees: AstraZeneca, GSK, Bial, Sanofi, Medinfar; Participation in a company sponsored speaker’s bureau: AstraZeneca, Sanofi. M.M. reports the following competing interests: advisory board honoraria, lecture honoraria and travel bursary from AstraZeneca, Chiesi, and Menarini. A.B. reports no relevant competing interests. W.L.W. reports the following competing interests: Consultant and speaker for AstraZeneca. A.U. reports no relevant competing interests. T.W. reports the following competing interests: consultant for unbranded disease awareness, education, advocacy & research for AstraZeneca, Chiesi, GSK, Novartis, and Sanofi Regeneron. S.B. reports the following competing interests: Speakers Bureau: Boehringer Ingelheim, AstraZeneca.
: This declaration is not applicable, as this work did not involve patient-level data.<b>CME certification</b>Readers of this article may receive continuing medical education (CME) credit by completing the survey below, depending on their local regulating bodies. Survey link: .
